Property:RefDocPart
From GxPlex
Article, annex, or section this reference covers.
E
Article 2
Paragraph 45 +
Article 2
Paragraph 46 +
Article 2
Paragraph 62 +
G
GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 2 adverse event adverse reaction +
Article 2
adverse event
adverse reaction +
GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 2 clinical trial +
Article 2
clinical trial +
Article 2
in vitro diagnostic medical device +
GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 2 investigational medicinal product +
Article 2
investigational medicinal product +
GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 2 investigator +
Article 2
investigator +
Article 2
medical device +
GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 2 non-interventional trial +
Article 2
non-interventional trial +
GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 2 relevant ethics committee +
Article 2
relevant ethics committee +
GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 2 serious adverse event +
Article 2
serious adverse event +
GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 2 unexpected adverse reaction +
Article 2
unexpected adverse reaction +
E
EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 2 Paragraph 11 +
Article 2
Paragraph 11 +
EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 2 Paragraph 14 +
Article 2
Paragraph 14 +
Article 2
Paragraph 2
No. 1 +
Article 2
Paragraph 2
No. 2 +
Article 2
Paragraph 2
No. 3 +
Article 2
Paragraph 2
No. 4 +
EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 2 Paragraph 2 – 3 +
Article 2
Paragraph 2 – 3 +